Chapter 20 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.

Slides:



Advertisements
Similar presentations
Chapter 5 Companion site for Basic Medical Endocrinology, 4th Edition Author: Dr. Goodman.
Advertisements

Chapter 6 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
Chapter 22 Energy balance Metabolism Homeostatic control of metabolism
Chapter 10 PART II: Concepts in Molecular Biology and Genetics Integrative Systems Biology: Implications for the Understanding of Human Disease Companion.
Chapter 14 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
Goals: 1) Understand the mechanism for ↑LDL in Type II diabetes 2) Having previously established the link between endothelial cell damage (loss of inhibitory.
Chapter 20 PART IV: Molecular Pathology of Human Disease Molecular Basis of Liver Disease Companion site for Molecular Pathology Author: William B. Coleman.
Endocrine Block Glucose Homeostasis Dr. Usman Ghani.
Chapter 12 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
Chapter 6 PART II: Concepts in Molecular Biology and Genetics The Human Genome: Implications for the Understanding of Human Disease Companion site for.
Chapter 14 PART IV: Molecular Pathology of Human Disease Molecular Basis of Cardiovascular Disease Companion site for Molecular Pathology Author: William.
Hepatic Steatosis Chen-Yu Wang
Date of download: 7/3/2016 From: Efficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes Ann Intern Med. 2000;133(4): doi: /
The Endocrine Pancreas
Samir Parekh, Frank A. Anania  Gastroenterology 
Nutritional therapy for nonalcoholic fatty liver disease
Oxidants and antioxidants in alcohol-induced liver disease
Volume 139, Issue 1, Pages e7 (July 2010)
Toxic responses of the liver
Volume 16, Issue 3, Pages (July 2016)
Oxidants and antioxidants in alcohol-induced liver disease
Volume 47, Issue 1, Pages (July 2007)
Nonalcoholic steatohepatitis
Volume 57, Issue 5, Pages (November 2012)
Fatty Acid-Induced T Cell Loss Greases Liver Carcinogenesis
Samir Parekh, Frank A. Anania  Gastroenterology 
NAFLD, Obesity, and Bariatric Surgery
Roles for Chemokines in Liver Disease
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Volume 124, Issue 1, Pages (January 2003)
NASH: a mitochondrial disease
Volume 129, Issue 1, Pages (July 2005)
Ludger Scheja, Joerg Heeren  Journal of Hepatology 
Volume 129, Issue 5, Pages (November 2005)
Frank J. Gonzalez, Changtao Jiang, Andrew D. Patterson 
Volume 141, Issue 4, Pages e5 (October 2011)
A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches  Ekihiro Seki, David A. Brenner, Michael.
Nat. Rev. Endocrinol. doi: /nrendo
Sugar, Sugar Not So Sweet for the Liver
Volume 62, Issue 1, Pages (January 2015)
Volume 138, Issue 2, Pages e1 (February 2010)
Volume 132, Issue 1, Pages (January 2007)
Figure 1 Key mechanistic pathways involved in the gut–liver axis in NAFLD progression Figure 1 | Key mechanistic pathways involved in the gut–liver axis.
Figure 6 Possible therapeutic targets to decrease hepatic steatosis
Volume 24, Issue 6, Pages (August 2018)
Volume 61, Issue 6, Pages (December 2014)
Bile Acids Activate YAP to Promote Liver Carcinogenesis
Volume 134, Issue 4, Pages (April 2008)
“De-liver-ance” From CB1: A Way to Counteract Insulin Resistance?
Volume 120, Issue 5, Pages (April 2001)
Chapter 6 Transcription of Genes
The genetics of alcohol dependence and alcohol-related liver disease
Volume 69, Issue 4, Pages (October 2018)
Volume 130, Issue 7, Pages (June 2006)
Volume 140, Issue 6, Pages (March 2010)
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
Claire Z. Larter, Geoffrey C. Farrell  Journal of Hepatology 
NASH animal models: Are we there yet?
Figure 1 NAFLD pathogenesis
Volume 61, Issue 6, Pages (December 2014)
Bile Acids Activate YAP to Promote Liver Carcinogenesis
IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis  Shin Maeda, Hideaki Kamata, Jun-Li.
Knockdown of MPST weakens JNK phosphorylation, ameliorates hepatic oxidative stress and suppresses the release of MCP-1. Knockdown of MPST weakens JNK.
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease  Michal Pawlak,
Toxic responses of the liver
Volume 131, Issue 5, Pages (November 2006)
Figure 1 Thyroid hormone effects on hepatic lipid metabolism
A B Figure S1, Effect of CH diet consumption for six weeks on mice hepatic morphology. Representative histologic microphotographs of H&E stained liver.
Volume 135, Issue 6, Pages (December 2008)
Presentation transcript:

Chapter 20 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis

Companion site for Molecular Pathology Copyright © 2009 by Academic Press. All rights reserved. 2 FIGURE 20.1 Summary of molecular signaling during liver development in mouse. Abbreviations: FGFFibroblast growth factor; BMPBone morphogenic protein; AFPα-fetoprotein; AlbAlbumin; HGFHepatocyte growth factor; HNFHepatocyte nuclear factor; C/EBPαCCAAT enhancer binding protein- alpha.

Companion site for Molecular Pathology Copyright © 2009 by Academic Press. All rights reserved. 3 FIGURE 20.2 H&E of developing mouse livers. (A) Several hematopoietic cells (arrow) are seen interspersed among hepatoblasts (arrowhead), which display large nuclei and scanty cytoplasm, in an E14 liver section. (B) Fewer hematopoietic cells (arrow) are observed among the hepatocytes (arrowhead) which begin to show cuboidal morphology and large clear cytoplasm as well as begin to display polarity, in an E17 liver section. (C) Similar cuboidal morphology of hepatocytes (arrowhead) is seen in an E19 mouse liver.

Companion site for Molecular Pathology Copyright © 2009 by Academic Press. All rights reserved. 4 FIGURE 20.3 H&E and TUNEL immunohistochemistry exhibiting apoptotic cell death after Fas- and TNFα-mediated liver injury. (A) H&E shows massive cell death 6 hours after Jo-2 antibody administration. (B) Several TUNEL-positive apoptotic nuclei (arrowheads) are evident in the same liver. (C) H&E shows massive cell death 7 hours after D-galactosamine/LPS administration in mice. (D) Several TUNEL-positive apoptotic nuclei (arrowhead) are evident in the same liver.

Companion site for Molecular Pathology Copyright © 2009 by Academic Press. All rights reserved. 5 FIGURE 20.4 Molecular basis of nonalcoholic steatohepatitis. Insulin resistance results in decreased insulin-induced inhibition of hormone-sensitive lipase (HSL) activity in adipocytes resulting in high rates of lipolysis and increased plasma free fatty acid (FFA) levels. High plasma FFA levels increase FFA flux to the liver. In myocytes, insulin resistance results in decreased glucose uptake and high plasma glucose and insulin levels. In the liver, hyperinsulinemia activates SREBP- 1c, leading to increased transcription of lipogenic genes. High plasma glucose levels simultaneously activate ChREBP, which activates glycolysis and lipogenic genes. SREBP-1c and ChREBP act synergistically to convert excess glucose to fatty acids. Increased FFA flux and increased lipogenesis increases the total hepatic FFA pool. The increased hepatic FFA pool can either be converted to triglycerides for storage or transport out of the liver as very low density lipoprotein or undergo oxidation in mitochondria, peroxisomes, or endoplasmic reticulum. Increased reactive oxygen species generated during fatty acid oxidation causes lipid peroxidation, which subsequently increases oxidative stress, inflammation, and fibrosis.

Companion site for Molecular Pathology Copyright © 2009 by Academic Press. All rights reserved. 6 FIGURE 20.5 Fatty liver disease along with hepatic fibrosis. (A) Patient with NAFLD shows significant macrovesicular (arrowhead) and microvesicular steatosis (blue arrowhead) in a representative H&E stain. (B) Masson trichrome staining of liver from mouse on methionine and choline-deficient diet for 4 weeks reveals hepatic fibrosis (arrow) along with macrovesicular steatosis (arrowheads).

Companion site for Molecular Pathology Copyright © 2009 by Academic Press. All rights reserved. 7 FIGURE 20.6 Histology and immunohistochemistry for β-catenin in pediatric hepatoblastomas. (A) H&E displaying embryonal pattern of hepatoblastoma. (B) H&E displaying small cell embryonal hepatoblastoma. (C) H&E displaying fetal hepatoblastoma. (D) Nuclear and cytoplasmic localization of β-catenin in an embryonal hepatoblastoma. (E) Nuclear localization of β-catenin along with some membranous staining in a fetal hepatoblastoma.

Companion site for Molecular Pathology Copyright © 2009 by Academic Press. All rights reserved. 8 FIGURE 20.7 Histology of hepatic adenoma and HCC in mouse model of chemical carcinogenesis and HCC in patients. (A) A hepatic adenoma (*) is evident on H&E in mice 6 months after diethylnitrosamine (DEN) injection. (B) HCC (*) is evident in mouse liver 9 months after DEN injection. (C) H&E show abnormal trabecular pattern (arrowheads) in HCC patient. (D) H&E showing fibrolamellar variant of HCC in a patient with lamellar fibrosis (arrowhead) pattern surrounding large tumor cells (arrows).